Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic

Int J Drug Policy. 2021 Jun:92:103053. doi: 10.1016/j.drugpo.2020.103053. Epub 2020 Nov 24.

Abstract

Background: The ongoing COVID-19 pandemic strains the medical system, limiting access to healthcare services. Many people use cannabis medically for chronic health conditions and as a substitute for other medications. As such, changes in cannabis access associated with COVID-19 may result in increased non-cannabis drug use.

Methods: We recruited N = 353 individuals through Amazon Mechanical Turk who reported current medical cannabis use in April and May of 2020. We assessed the effects of the COVID-19 pandemic on patterns of medication and substance use, as well as on cannabis use patterns.

Results: Over half of participants either started using or increased use of medications or substances because of the COVID-19 pandemic, most commonly alcohol and sleep aids. Over a third of participants increased cannabis use while 25% decreased cannabis use. Approximately 40% of participants who increased or started use of medications/substances (other than cannabis) reported doing so because of changed access to medical cannabis.

Conclusion: The reported increase in drug use among people using medical cannabis is concerning. Because the pandemic will likely continue for months (or even years), having a better understanding of why this is occurring is critical for developing effective harm-reduction strategies in this population.

Keywords: Alcohol; Covid-19; Drug use; Medical cannabis; Substitution.

MeSH terms

  • COVID-19*
  • Cannabis*
  • Humans
  • Pandemics
  • SARS-CoV-2
  • Substance-Related Disorders* / complications
  • Substance-Related Disorders* / epidemiology